New Pharmacotherapy Targeting Cognitive Dysfunction of Schizophrenia via Modulation of GABA Neuronal Function

Schizophrenia is considered a neurodevelopmental and neurodegenerative disorder. Cognitive impairment is a core symptom in patients with the illness, and has been suggested a major predictor of functional outcomes. Reduction of parvalbumin (PV)-positive γ-aminobutyric acid (GABA) interneurons has be...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Won Je, Sumiyoshi, Tomiki, Kurachi, Masayoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759318/
https://www.ncbi.nlm.nih.gov/pubmed/26630957
http://dx.doi.org/10.2174/1570159X13666151009120153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759318/
https://www.ncbi.nlm.nih.gov/pubmed/26630957
http://dx.doi.org/10.2174/1570159X13666151009120153

Ejemplares similares